Takeda Biopharmaceuticals India showcased digital innovations- MyPKFit, SYNAPSE and Athena at the G20 Health Working Group Meeting
Takeda Biopharmaceuticals India showcased its digital innovations at the G20 Health Working Group meeting, held in Goa, India, from April 17th to April 19th.
The G20 meeting’s focus was ‘Citizen-Centric Health Delivery Ecosystems for Universal Health Coverage leveraging Digital Health and Innovations,’ where discussions were held on creating a digital health ecosystem, innovations in healthcare, technology aiding continuing care, and digital public health goods. The meeting was attended by representatives of G20 member countries, special invitee countries, and relevant international organisations.
Details of the three solutions presented at the event can be found here:
MyPKFit: MYPKFIT, FDA approved application, offers personalised and interactive prophylaxis treatment option that enables both healthcare professionals (HCPs) and patients in real-time monitoring of factor VIII levels on smartphones thereby adapting their activity decisions accordingly and help improve their quality of life. Alerts are sent to patients on prophylaxis when their estimated factor VIII levels are low, and reminds them when their infusions are due, thereby providing excellent prophylactic coverage.
Synapse: Synapse is a valuable platform designed to enhance awareness and knowledge sharing among healthcare professionals (HCPs), in line with Takeda’s core philosophy of “better health, brighter future.” With its scientific and value-driven approach, Synapse has successfully engaged over 4000 HCPs through scientific exchange and educational initiatives, leading to significant positive impact on many lives. The platform’s primary objective is to improve awareness and enhance standards of care, thereby optimizing patient benefits. Synapse also fosters academic partnerships with scientific societies to help build quality HCP education and awareness. Furthermore, it aims to identify unmet medical needs, gather insights, and provide patient health improvement-oriented solutions to improve standards of care. In essence, Synapse is a comprehensive and innovative platform that seeks to empower HCPs with the knowledge and tools necessary to make a positive impact on patients’ lives.
Athena: The Athena App MVP is a digital health solution that enables remote patient data capture and improved patient engagement for Anaplastic Lymphoma Kinase Positive (ALK+) Non-Small Cell Lung Cancer (NSCLC) patients, their caregivers, and healthcare professionals (HCPs). The MVP will consist of three elements: a device-agnostic app for patients, a Fitbit wearable device, and a web-based portal or PDF summary for HCPs. The functionalities of the Athena App MVP support tracking of passive and active metrics of Quality of Life (QOL) for NSCLC patients, HCPs, and researchers. The patient-centered app enables remote tracking of symptoms, quality of life, medications, activity, and educational content. Patients receive all tasks in a timeline and can add reminders, while also completing bespoke or validated questionnaires such as EQ5D5L. The Fitbit wearable device captures key metrics that can inform a patient’s and HCP’s view of Quality of Life. HCPs can access patient data generated from the app through a web-based portal or PDF summary, which incorporates telemedicine and messaging for direct communication.